16:20 EST Cytokinetics (CYTK) trading resumes
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYTK:
- Cytokinetics announces FDA approval of Myqorzo
- Cytokinetics trading halted, news pending
- Cytokinetics upgraded to Buy at Goldman on odds of ACACIA succeeding
- Cytokinetics upgraded to Buy from Neutral at Goldman Sachs
- Cytokinetics Poised for Global Growth with MYQORZO Approval and Anticipated Regulatory Milestones